Seegene Using Molzym DNA-Enrichment Tech for Multiplex PCR Sepsis Test

Molzym is providing its MolYsis microbial DNA-enrichment technology, which the company claims enables up to 40,000-fold DNA enrichment over conventional technologies, on the front end of Seegene's Magicplex Sepsis test.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.